Nephros, Inc. (NEPH) Stock

Nephros, Inc. specializes in delivering advanced water solutions tailored for medical and commercial applications across the United States. Operating through three distinct segments Water Filtration, Pathogen Detection, and Renal Products the company provides a range of innovative technologies. Its ultrafiltration products are pivotal in dialysis centers, effectively removing biological contaminants from water and bicarbonate concentrate. These products also play a crucial role in hospitals, where they mitigate the risk of infections caused by waterborne pathogens like legionella and pseudomonas. Moreover, Nephros serves diverse sectors including military, outdoor recreation, commercial facilities, and various healthcare settings.

In addition to its ultrafiltration solutions, Nephros develops and markets real-time water testing systems that deliver actionable insights into waterborne pathogens. This technology is essential for ensuring water safety across different environments. The company also designs medical devices tailored for patients with renal disease, including a sophisticated 2nd generation hemodiafiltration system for treating individuals with end-stage renal disease. Furthermore, Nephros offers water filtration solutions under the Nephros and AETHER brands, enhancing water quality by improving taste, reducing odor, and minimizing biofilm, bacteria, and scale buildup. These products cater specifically to the food service, hospitality, convenience store, and healthcare markets.

Founded in 1997 and headquartered in South Orange, New Jersey, Nephros, Inc. has established itself as a leader in water purification technologies. With a commitment to innovation and quality, the company continues to expand its reach and impact in both medical and commercial sectors, striving to address critical needs for clean, safe water across diverse industries.